secwatch.observer — SEC 8-K summary
======================================

Issuer:     Century Therapeutics, Inc. (IPSC)
CIK:        0001850119
Form:       8-K
Filed at:   2024-01-19T23:59:59+00:00
Accession:  0001104659-24-005271
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Century Therapeutics CFO Michael Diem resigns; Douglas Carr named interim CFO
-----------------------------------------------------------------------------

- CFO Michael C. Diem resigned effective Feb 2, 2024; company has initiated a search for a permanent replacement.
- Douglas Carr, SVP Finance and Operations, will serve as interim principal financial officer following Dr. Diem's departure.
- Dr. Diem's resignation is not due to any disagreement with the company's operations, policies, or practices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850119/000110465924005271/0001104659-24-005271-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850119/000110465924005271/tm243558d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-005271

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer